GSK launches Flonase ahead of allergy season

GSK Consumer Healthcare has launched Flonase Allergy Relief for the treatment of seasonal allergies.
“For more than 50 million Americans who suffer from allergies, the burden is more than just a stuffy nose,” Clifford Bassett, founder and medical director of allergy and asthma care of New York state, said in a news release. “Uncontrolled allergies have a measurable impact on quality of life, affecting children and adults. In my patient population, having a proactive treatment plan in place makes a big difference in managing their allergies.”
Flonase Senior Brand Manager Jennifer Nadelson noted GSK has a strong heritage in discovering and developing respiratory products to meet patient needs worldwide.
“With Flonase we’re proud to offer allergy sufferers an additional product option providing more complete symptom relief in a new, unique, user-friendly device,” she said.